BioLife Solutions (BLFS) Misses Q2 EPS by 30c ; Offers Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.25 -0.79%
Revenue Growth %: +3.3%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.3%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.33), $0.30 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $25.42 million versus the consensus estimate of $23.71 million.
GUIDANCE:
BioLife Solutions sees FY2025 revenue of $100-103 million, versus the consensus of $97.76 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
